124 related articles for article (PubMed ID: 12859262)
1. Aqueous humour flow after a single oral dose of isosorbide-5-mononitrate in healthy volunteers.
Kotikoski H; Oksala O; Vapaatalo H; Aine E
Acta Ophthalmol Scand; 2003 Aug; 81(4):355-60. PubMed ID: 12859262
[TBL] [Abstract][Full Text] [Related]
2. The effect of isosorbide-mononitrate eye drops on the human intraocular pressure and aqueous humor dynamics.
Diestelhorst M; Hinzpeter B; Krieglstein GK
Int Ophthalmol; 1991 Jul; 15(4):259-62. PubMed ID: 1917320
[TBL] [Abstract][Full Text] [Related]
3. Aqueous humor flow in normal human eyes treated with brimonidine and timolol, alone and in combination.
Larsson LI
Arch Ophthalmol; 2001 Apr; 119(4):492-5. PubMed ID: 11296014
[TBL] [Abstract][Full Text] [Related]
4. Diurnal and nocturnal variations in aqueous humor dynamics of patients with ocular hypertension undergoing medical therapy.
Gulati V; Fan S; Zhao M; Maslonka MA; Gangahar C; Toris CB
Arch Ophthalmol; 2012 Jun; 130(6):677-84. PubMed ID: 22332206
[TBL] [Abstract][Full Text] [Related]
5. Effects of D-timolol and L-timolol eye drops on intraocular pressure and aqueous flow. A dose-response study in normal eyes.
Alm A; Koskela T; Taarnhøj J
Acta Ophthalmol (Copenh); 1990 Feb; 68(1):19-22. PubMed ID: 2336928
[TBL] [Abstract][Full Text] [Related]
6. The effect of latanoprost 0.005% once daily versus 0.0015% twice daily on intraocular pressure and aqueous humour protein concentration in glaucoma patients. A randomized, double-masked comparison with timolol 0.5%.
Diestelhorst M; Roters S; Krieglstein GK
Graefes Arch Clin Exp Ophthalmol; 1997 Jan; 235(1):20-6. PubMed ID: 9034838
[TBL] [Abstract][Full Text] [Related]
7. Single-dose effects of isosorbide mononitrate alone or in combination with losartan on central blood pressure.
Kaufman R; Nunes I; Bolognese JA; Miller DL; Salotti D; McCarthy JM; Smith WB; Herman GA; Feig PU
J Am Soc Hypertens; 2010; 4(6):311-8. PubMed ID: 21130977
[TBL] [Abstract][Full Text] [Related]
8. The efficacy of two different doses of vaginal isosorbide mononitrate in pre induction cervical ripening: a double blind randomised controlled trial.
Vidanagamage RS; Goonewardene IM
Ceylon Med J; 2011 Sep; 56(3):91-100. PubMed ID: 22164745
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the early effects of brimonidine and apraclonidine as topical ocular hypotensive agents.
Maus TL; Nau C; Brubaker RF
Arch Ophthalmol; 1999 May; 117(5):586-91. PubMed ID: 10326954
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of oral route isosorbide 5-mononitrate on peritoneal solute and fluid transports in CAPD patients.
Kanjanabuch T; Eiam-Ong S
J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S129-37. PubMed ID: 17044464
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and mechanisms of intraocular pressure reduction with latanoprost and timolol in participants with ocular hypertension: a comparison of 1 and 6 weeks of treatment.
Johnson TV; Fan S; Zhan G; Camras CB; Toris CB
J Glaucoma; 2010 Aug; 19(6):356-64. PubMed ID: 20179619
[TBL] [Abstract][Full Text] [Related]
12. Comparison of dorzolamide and timolol as suppressors of aqueous humor flow in humans.
Wayman L; Larsson LI; Maus T; Alm A; Brubaker R
Arch Ophthalmol; 1997 Nov; 115(11):1368-71. PubMed ID: 9366665
[TBL] [Abstract][Full Text] [Related]
13. Interactions of L-arginine, isosorbide mononitrate, and angiotensin II inhibitors on arterial pulse wave.
Stokes GS; Barin ES; Gilfillan KL; Kaesemeyer WH
Am J Hypertens; 2003 Sep; 16(9 Pt 1):719-24. PubMed ID: 12944028
[TBL] [Abstract][Full Text] [Related]
14. Combination of systemic acetazolamide and topical dorzolamide in reducing intraocular pressure and aqueous humor formation.
Rosenberg LF; Krupin T; Tang LQ; Hong PH; Ruderman JM
Ophthalmology; 1998 Jan; 105(1):88-92; discussion 92-3. PubMed ID: 9442783
[TBL] [Abstract][Full Text] [Related]
15. Effects of Topical Bimatoprost 0.01% and Timolol 0.5% on Circadian IOP, Blood Pressure and Perfusion Pressure in Patients with Glaucoma or Ocular Hypertension: A Randomized, Double Masked, Placebo-Controlled Clinical Trial.
Oddone F; Rossetti L; Tanga L; Berardo F; Ferrazza M; Michelessi M; Roberti G; Manni G; Centofanti M
PLoS One; 2015; 10(10):e0140601. PubMed ID: 26484767
[TBL] [Abstract][Full Text] [Related]
16. Effects of apraclonidine on aqueous humor dynamics in human eyes.
Toris CB; Tafoya ME; Camras CB; Yablonski ME
Ophthalmology; 1995 Mar; 102(3):456-61. PubMed ID: 7891985
[TBL] [Abstract][Full Text] [Related]
17. Clinical potential of combined organic nitrate and phosphodiesterase type 5 inhibitor in treatment-resistant hypertension.
Oliver JJ; Hughes VE; Dear JW; Webb DJ
Hypertension; 2010 Jul; 56(1):62-7. PubMed ID: 20479335
[TBL] [Abstract][Full Text] [Related]
18. The role of sustained release isosorbide mononitrate on corticosteroid-induced hypertension in healthy human subjects.
Williamson PM; Ong SL; Whitworth JA; Kelly JJ
J Hum Hypertens; 2015 Dec; 29(12):737-43. PubMed ID: 25810066
[TBL] [Abstract][Full Text] [Related]
19. Aqueous humour concentration and the intraocular pressure-lowering effect of topical betaxolol before cataract surgery.
Vainio-Jylhä E; Vuori ML; Kaila T; Huupponen R
Eur J Clin Pharmacol; 1998 Jul; 54(5):389-92. PubMed ID: 9754981
[TBL] [Abstract][Full Text] [Related]
20. Preserved endothelial function after long-term eccentric isosorbide mononitrate despite moderate nitrate tolerance.
Müller S; Laber U; Müllenheim J; Meyer W; Kojda G
J Am Coll Cardiol; 2003 Jun; 41(11):1994-2000. PubMed ID: 12798571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
